Insider Activity of Third Rock Ventures V, L.P.
According to the SEC Form 4 filings, Third Rock Ventures V, L.P., being in a position of
- 10 percent owner at Rapport Therapeutics, Inc. Common Stock,оver the last 12 months, has bought 0 shares, and sold 854708 shares for $34.39M,over all time since 2026-04-17, has bought 0 shares, and sold 854708 shares for $34.39M.
Biography of Third Rock Ventures V, L.P.
No biography is available at this moment.